AB0 blood group and prognosis in patients with pancreatic cancer

Although blood group 0 is associated with a reduced risk of pancreatic cancer, little is known about the role of AB0 blood group antigens in disease progression. We assessed the prognostic relevance of AB0 blood status in a large cohort of patients with resected pancreatic cancer.

Saved in:
Bibliographic Details
Main Authors: Rahbari, Nuh Nabi (Author) , Bork, Ulrich (Author) , Hinz, Ulf (Author) , Leo, Albrecht (Author) , Kirchberg, Johanna (Author) , Koch, Moritz (Author) , Büchler, Markus W. (Author) , Weitz, Jürgen (Author)
Format: Article (Journal)
Language:English
Published: 28 July 2012
In: BMC cancer
Year: 2012, Volume: 12, Issue: 1
ISSN:1471-2407
DOI:10.1186/1471-2407-12-319
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/1471-2407-12-319
Verlag, kostenfrei, Volltext: https://doi.org/10.1186/1471-2407-12-319
Get full text
Author Notes:Nuh N. Rahbari, Ulrich Bork, Ulf Hinz, Albrecht Leo, Johanna Kirchberg, Moritz Koch, Markus W. Büchler and Jürgen Weitz
Description
Summary:Although blood group 0 is associated with a reduced risk of pancreatic cancer, little is known about the role of AB0 blood group antigens in disease progression. We assessed the prognostic relevance of AB0 blood status in a large cohort of patients with resected pancreatic cancer.
Item Description:Gesehen am 26.11.2018
Physical Description:Online Resource
ISSN:1471-2407
DOI:10.1186/1471-2407-12-319